(Total Views: 120)
Posted On: 09/15/2022 3:40:47 PM
Post# of 85344
$BMY News Article - Bristol Myers Squibb Announces Adjuvant Treatment with Opdivo (nivolumab) Demonstrated Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival (RFS) in Patients with Stage IIB/C Melanoma in the CheckMate -76K Trial https://marketwirenews.com/news-releases/bris...16157.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
